Dendreon

Dendreon Preview: Drama Could Culminate in the First Cancer Vaccine Approval
BNET Pharma
Fri, 04/23/10 - 11:26 am
Dendreon
vaccines
Provenge
prostate cancer
Will AspenBio Pharma Follow in Dendreon and Human Genome Sciences' Footsteps?
Seeking Alpha
Thu, 04/22/10 - 07:30 am
AspenBio
Novartis
Human Genome Sciences
Dendreon
Dendreon touts Provenge test results
Bizjournals.com
Wed, 04/21/10 - 03:52 pm
Provenge
prostate cancer
Dendreon
How much is too much to pay for Provenge?
Fierce Biotech
Wed, 04/14/10 - 11:34 am
Provenge
Dendreon
prostate cancer
Seven Biotech Drugs to Watch in the Second Quarter
BNET Pharma
Tue, 04/13/10 - 10:35 am
Acorda Therapeutics
AMPYRA
Cell Therapeutics
pixantrone
Pixuvri
Dendreon
Provenge
InterMune
Esbriet
Pozen
Vimovo
XenoPort
Horizant
Astellas
OSI Pharmaceuticals
Ironwood
Antigenics Should Emerge From Dendreon's Shadow Soon
Seeking Alpha
Tue, 04/13/10 - 09:52 am
Antigenics
Dendreon
Bristol-Myers Squibb
GSK
Cel-Sci
cancer vaccines
Keryx Biopharmaceuticals Could Easily Triple Within the Next Year
Seeking Alpha
Mon, 04/12/10 - 09:04 am
Dendreon
Keryx
Merck
Pfizer
Ranbaxy
Sanofi
A blockbuster FDA deadline looms and Dendreon shares turn red-hot
Fierce Biotech
Wed, 04/7/10 - 11:46 am
Dendreon
Provenge
FDA
prostate cancer
14 Biotech Stocks Facing FDA Approval
TheStreet.com
Wed, 04/7/10 - 10:01 am
Cell Therapeutics
Pozen
AstraZeneca
Dendreon
InterMune
Questcor Pharmaceuticals
Novartis
Biogen Idec
Teva Pharmaceuticals
Merck Serono
Savient
Javelin
Alexza
Human Genome
Jazz Pharmaceuticals
Arena Pharmaceuticals
Vivus
Biodel
1 Month to Go! Is Dendreon a Buy?
Motley Fool
Mon, 04/5/10 - 07:11 pm
Dendreon
Provenge
prostate cancer
Biotech Calendar: Key Dates for April
TheStreet.com
Mon, 04/5/10 - 09:53 am
Forest Labs
Celgene
Genzyme
Lexicon Pharmaceuticals
Cell Therapeutics
Acadia
Acorda Therapeutics
Vertex Pharmaceuticals
Indenix
Pozen
Acura Pharmaceuticals
OSI Pharmaceuticals
Cyclacel
Peregrine Pharmaceuticals
Anadys
Pharmasset
Dendreon
Dendreon To Celebrate May Day
Investors.com
Fri, 03/26/10 - 09:03 am
Dendreon
What to Expect for Biotech Stocks
Minyanville
Fri, 03/19/10 - 09:03 am
biotech
Cell Therapeutics
Somaxon
Dendreon
Allos
GenVec
Arena Pharmaceuticals
Vivus
10 Biotech Stocks On the Line
TheStreet.com
Thu, 03/11/10 - 08:57 am
Medivation
InterMune
Allos
Affymax
Amylin
Alkermes
Cell Therapeutics
Delcath
Dendreon
GenVec
MannKind
Somaxon
Vertex Pharmaceuticals
For Biotech in 2010, It's Déjà Vu All Over Again
Seeking Alpha
Mon, 03/8/10 - 10:23 am
Alkermes
Amylin
MannKind
Cell Therapeutics
Dendreon
Isis Pharmaceuticals
Amag Pharmaceuticals
XenoPort
Novelos Therapeutics
Adventrx
Delcath
Investors Show Confidence in Dendreon
Seeking Alpha
Mon, 03/8/10 - 09:06 am
Dendreon
Dendreon and the Prostate Cancer Battle
Minyanville
Thu, 03/4/10 - 06:06 pm
Dendreon
Provenge
prostate cancer
Rogue Analyst Provides Questionable Fodder for Dendreon Conspiracy Theorists
BNET Pharma
Thu, 03/4/10 - 07:15 am
Provenge
prostate cancer
Dendreon
Sanofi's Cancer Drug May Set New Standard
TheStreet.com
Thu, 03/4/10 - 07:13 am
Sanofi
cabazitaxel
Medivation
JNJ
Provenge
Dendreon
prostate cancer
No Panel For Provenge
Forbes
Tue, 03/2/10 - 02:14 pm
Dendreon
Provenge
FDA

Pages